EUVIMEDEUVIMED entdecken
Multizentrische StudieBeobachtungsstudieOpen Access · CC BY-NC 4.0

Methicillin‐resistant Staphylococcus aureus bloodstream infections in the Northern Territory of Australia 2017–2022

Sara Davison iD, Aliya Bryce, Duncan Campbell, Robert Baird, Thomas Ewin, Shahid Ullah, Sonja Janson, Danny Tsai

Internal Medicine Journal · 2026-07 · 56 (7) · 1200-1208

DOI: 10.1111/imj.70472 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Internal Medicine Journal, online erschienen am 23.05.2026. Verfasst von Sara Davison und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Infectious Diseases, Royal Darwin Hospital, Darwin, Northern Territory, Australia. Hauptthemen laut MEDLINE: Staphylococcal Infections, Methicillin-Resistant Staphylococcus aureus, Bacteremia. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Methicillin‐resistant Staphylococcus aureus (MRSA) bloodstream infections (BSIs) cause significant morbidity and mortality. In Australia's Northern Territory (NT), MRSA BSI prevalence is disproportionately high. Vancomycin remains standard therapy despite toxicity and complex monitoring requirements.

Aim

To evaluate demographics, clinical management and outcomes of patients with MRSA BSI in the NT, with a focus on health inequities.

Methods

This multi‐centre retrospective observational study analysed MRSA BSI episodes in hospitalised adults between 2017 and 2022 at the Royal Darwin and Alice Springs Hospitals. Key data were extracted from electronic medical records. Composite treatment failure was defined as follows: outcome of all‐cause 90‐day mortality, persistent bacteraemia (>7 days) or 90 day relapse.

Results

Of 182 identified episodes, MRSA accounted for 40% of all S. aureus BSIs. First Nations Australians were disproportionately affected, representing 69% of episodes, with an incidence rate 3.3 times higher than non‐Indigenous residents. The composite treatment failure rate was 18%, and 90‐day mortality was 13%. Age ≥ 50 years was the only independent variable associated with treatment failure. Notably, 19% of patients required an antimicrobial switch from vancomycin, frequently due to adverse drug reactions. Vancomycin minimum inhibitory concentration (MIC) testing showed high discordance between VITEK2 and E ‐Test.

Conclusion

MRSA bloodstream infections remain a significant challenge in the NT, largely due to social and structural factors disproportionately affecting First Nations Australians. While strategies to prevent invasive bloodstream infections should be prioritised, the high incidence of vancomycin‐related adverse events and MIC discordance underscores the urgent need for stable, effective oral antimicrobial alternatives and culturally safe, community‐led prevention strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Staphylococcal InfectionsMethicillin-Resistant Staphylococcus aureusBacteremiaHumansNorthern TerritoryRetrospective StudiesFemaleAnti-Bacterial AgentsMiddle AgedAgedMaleVancomycinAdultMicrobial Sensitivity TestsAged, 80 and over

Stichwörter der Autor:innen

Northern TerritoryStaphylococcus aureusmethicillin‐resistant Staphylococcus aureusmicrobial sensitivity testsvancomycin

Substanzen

Anti-Bacterial AgentsVancomycin

Autor:innen und Institutionen

  • Department of Infectious Diseases, Royal Darwin Hospital, Darwin, Northern Territory, Australia.
  • Department of Infectious Diseases and Microbiology, Barts Health Trust, London, UK.
  • Department of General Medicine, Royal Melbourne Hospital, Melbourne, Victoria, Australia.
  • Department of Infectious Diseases, Alice Springs Hospital, Alice Springs, Northern Territory, Australia.
  • Department of Infectious Diseases, Barwon Health, Geelong, Victoria, Australia.
  • Territory Pathology, Darwin, Northern Territory, Australia.

ORCID-Profile: Sara Davison

Zitieren

APA

Davison, S., Bryce, A., Campbell, D., Baird, R., Ewin, T., Ullah, S., Janson, S., & Tsai, D. (2026). Methicillin‐resistant Staphylococcus aureus bloodstream infections in the Northern Territory of Australia 2017–2022. Internal Medicine Journal, 56(7), 1200-1208. https://doi.org/10.1111/imj.70472

Vancouver

Davison S, Bryce A, Campbell D, Baird R, Ewin T, Ullah S, et al. Methicillin‐resistant Staphylococcus aureus bloodstream infections in the Northern Territory of Australia 2017–2022. Internal Medicine Journal. 2026;56(7):1200-1208. doi:10.1111/imj.70472

BibTeX
@article{Davison2026,
  author = {Davison, Sara and Bryce, Aliya and Campbell, Duncan and Baird, Robert and Ewin, Thomas and Ullah, Shahid and Janson, Sonja and Tsai, Danny},
  title = {Methicillin‐resistant Staphylococcus aureus bloodstream infections in the Northern Territory of Australia 2017–2022},
  journal = {Internal Medicine Journal},
  year = {2026},
  volume = {56},
  number = {7},
  pages = {1200--1208},
  doi = {10.1111/imj.70472}
}
Kostenlos starten →